Zdrowie i gospodarka · 16/02/2018

FDA Clears Benazepril Hydrochloride; Hydrochlorothiazide Oral Tablets for Approval

The US Food and Drug Administration (FDA) has made a determination that Benazepril HCT oral tablets in 5mg and 6.25mg doses were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions of the medication.